Literature DB >> 18682402

Proto-oncogene FBI-1 (Pokemon) and SREBP-1 synergistically activate transcription of fatty-acid synthase gene (FASN).

Won-Il Choi1, Bu-Nam Jeon, Hyejin Park, Jung-Yoon Yoo, Yeon-Sook Kim, Dong-In Koh, Myung-Hwa Kim, Yu-Ri Kim, Choong-Eun Lee, Kyung-Sup Kim, Timothy F Osborne, Man-Wook Hur.   

Abstract

FBI-1 (Pokemon/ZBTB7A) is a proto-oncogenic transcription factor of the BTB/POZ (bric-à-brac, tramtrack, and broad complex and pox virus zinc finger) domain family. Recent evidence suggested that FBI-1 might be involved in adipogenic gene expression. Coincidentally, expression of FBI-1 and fatty-acid synthase (FASN) genes are often increased in cancer and immortalized cells. Both FBI-1 and FASN are important in cancer cell proliferation. SREBP-1 is a major regulator of many adipogenic genes, and FBI-1 and SREBP-1 (sterol-responsive element (SRE)-binding protein 1) interact with each other directly via their DNA binding domains. FBI-1 enhanced the transcriptional activation of SREBP-1 on responsive promoters, pGL2-6x(SRE)-Luc and FASN gene. FBI-1 and SREBP-1 synergistically activate transcription of the FASN gene by acting on the proximal GC-box and SRE/E-box. FBI-1, Sp1, and SREBP-1 can bind to all three SRE, GC-box, and SRE/E-box. Binding competition among the three transcription factors on the GC-box and SRE/E-box appears important in the transcription regulation. FBI-1 is apparently changing the binding pattern of Sp1 and SREBP-1 on the two elements in the presence of induced SREBP-1 and drives more Sp1 binding to the proximal promoter with less of an effect on SREBP-1 binding. The changes induced by FBI-1 appear critical in the synergistic transcription activation. The molecular mechanism revealed provides insight into how proto-oncogene FBI-1 may attack the cellular regulatory mechanism of FASN gene expression to provide more phospholipid membrane components needed for rapid cancer cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18682402      PMCID: PMC2662021          DOI: 10.1074/jbc.M802477200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

Review 1.  Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action.

Authors:  T F Osborne
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

2.  FBI-1 can stimulate HIV-1 Tat activity and is targeted to a novel subnuclear domain that includes the Tat-P-TEFb-containing nuclear speckles.

Authors:  P Shannon Pendergrast; Chen Wang; Nouria Hernandez; Sui Huang
Journal:  Mol Biol Cell       Date:  2002-03       Impact factor: 4.138

Review 3.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver.

Authors:  Jay D Horton; Joseph L Goldstein; Michael S Brown
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Flexible DNA binding of the BTB/POZ-domain protein FBI-1.

Authors:  Frank Pessler; Nouria Hernandez
Journal:  J Biol Chem       Date:  2003-05-15       Impact factor: 5.157

Review 5.  Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology.

Authors:  F P Kuhajda
Journal:  Nutrition       Date:  2000-03       Impact factor: 4.008

6.  Identification of nucleotides responsible for enhancer activity of sterol regulatory element in low density lipoprotein receptor gene.

Authors:  J R Smith; T F Osborne; J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1990-02-05       Impact factor: 5.157

7.  POZ domain transcription factor, FBI-1, represses transcription of ADH5/FDH by interacting with the zinc finger and interfering with DNA binding activity of Sp1.

Authors:  Dong-Kee Lee; Dongchul Suh; Howard J Edenberg; Man-Wook Hur
Journal:  J Biol Chem       Date:  2002-05-09       Impact factor: 5.157

8.  Fatty acid synthase drives the synthesis of phospholipids partitioning into detergent-resistant membrane microdomains.

Authors:  Johannes V Swinnen; Paul P Van Veldhoven; Leen Timmermans; Ellen De Schrijver; Koen Brusselmans; Frank Vanderhoydonc; Tine Van de Sande; Hannelore Heemers; Walter Heyns; Guido Verhoeven
Journal:  Biochem Biophys Res Commun       Date:  2003-03-21       Impact factor: 3.575

Review 9.  Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis.

Authors:  Javier A Menendez; Ruth Lupu
Journal:  Nat Rev Cancer       Date:  2007-10       Impact factor: 60.716

10.  Role of the POZ zinc finger transcription factor FBI-1 in human and murine adipogenesis.

Authors:  Matthias Laudes; Constantinos Christodoulides; Ciaran Sewter; Justin J Rochford; Robert V Considine; Jaswinder K Sethi; Antonio Vidal-Puig; Stephen O'Rahilly
Journal:  J Biol Chem       Date:  2003-12-30       Impact factor: 5.157

View more
  42 in total

1.  MicroRNA (miRNA)-mediated interaction between leukemia/lymphoma-related factor (LRF) and alternative splicing factor/splicing factor 2 (ASF/SF2) affects mouse embryonic fibroblast senescence and apoptosis.

Authors:  Lorena Verduci; Marcella Simili; Milena Rizzo; Alberto Mercatanti; Monica Evangelista; Laura Mariani; Giuseppe Rainaldi; Letizia Pitto
Journal:  J Biol Chem       Date:  2010-10-04       Impact factor: 5.157

2.  Stage-specific functions of leukemia/lymphoma-related factor (LRF) in the transcriptional control of osteoclast development.

Authors:  Kaori Tsuji-Takechi; Takako Negishi-Koga; Eriko Sumiya; Akiko Kukita; Shigeaki Kato; Takahiro Maeda; Pier Paolo Pandolfi; Keiji Moriyama; Hiroshi Takayanagi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-30       Impact factor: 11.205

3.  ZBTB2, a novel master regulator of the p53 pathway.

Authors:  Bu-Nam Jeon; Won-Il Choi; Mi-Young Yu; A-Rum Yoon; Myung-Hwa Kim; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2009-04-20       Impact factor: 5.157

4.  Inhibitory effects of sea buckthorn procyanidins on fatty acid synthase and MDA-MB-231 cells.

Authors:  Yi Wang; Fangyuan Nie; Jian Ouyang; Xiaoyan Wang; Xiaofeng Ma
Journal:  Tumour Biol       Date:  2014-06-24

Review 5.  Metabolic genes in cancer: their roles in tumor progression and clinical implications.

Authors:  Eiji Furuta; Hiroshi Okuda; Aya Kobayashi; Kounosuke Watabe
Journal:  Biochim Biophys Acta       Date:  2010-02-01

6.  Rare NRXN1 promoter variants in patients with schizophrenia.

Authors:  Abhishek K Shah; Nina M Tioleco; Karen Nolan; Joseph Locker; Katherine Groh; Catalina Villa; Pavla Stopkova; Erika Pedrosa; Herbert M Lachman
Journal:  Neurosci Lett       Date:  2010-03-25       Impact factor: 3.046

7.  Role of ornithine decarboxylase in regulation of estrogen receptor alpha expression and growth in human breast cancer cells.

Authors:  Qingsong Zhu; Lihua Jin; Robert A Casero; Nancy E Davidson; Yi Huang
Journal:  Breast Cancer Res Treat       Date:  2012-09-14       Impact factor: 4.872

Review 8.  Role of abnormal lipid metabolism in development, progression, diagnosis and therapy of pancreatic cancer.

Authors:  Julian Swierczynski; Areta Hebanowska; Tomasz Sledzinski
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

9.  Role of sp transcription factors in the regulation of cancer cell metabolism.

Authors:  Michael C Archer
Journal:  Genes Cancer       Date:  2011-07

10.  A novel POK family transcription factor, ZBTB5, represses transcription of p21CIP1 gene.

Authors:  Dong-In Koh; Won-Il Choi; Bu-Nam Jeon; Choong-Eun Lee; Chae-Ok Yun; Man-Wook Hur
Journal:  J Biol Chem       Date:  2009-06-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.